MarketBeatFri, 22 May 2026 04:05:16 GMTConnect Biopharma Touts Rademikibart's Edge as SEABREEZE Data Looms in 2026CNTB+1.44%
Seeking AlphaWed, 29 Apr 2026 14:08:58 GMTConnect Biopharma: New Market Opportunity In The Emergency SettingCNTB+1.44%
Seeking AlphaMon, 30 Mar 2026 21:12:05 GMTConnect Biopharma Holdings Limited (CNTB) Discusses Phase 3 Atopic Dermatitis Study Results and Updates on Rademikibart Development TranscriptCNTB+1.44%